In the Thorén lab we have a broad interest in human Natural killer (NK) cell biology. The research group comprises a mix of clinical and preclinical scientists and our research activities range from projects aiming at identifying novel NK cell receptor ligands to clinical immunotherapy trials.
Follow the links to learn more about our research within these five research themes:
A crispr approach to NK cell cytotoxicity